SecSonar.com

Perrigo Company plc (PRGO)

Perrigo Company plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Perrigo Company plc (PRGO) is a Drug Manufacturers - Specialty & Generic company based in IE with a market capitalization of $1.6B. Revenue declined 2.8% year-over-year and the company generated $145.1M in free cash flow. This page tracks PRGO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IE · 8.38K employees · IPO Dec 17, 1991

Valuation

Valuation & price

$10.61 · as of May 17, 2026 · -62.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.53

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$28.43$18.93$9.42Jul 25Dec 25Jul 26Jul 7, 25$26.74Jul 9, 25$27.22Jul 11, 25$27.53Jul 15, 25$27.05Jul 17, 25$27.15Jul 21, 25$26.94Jul 23, 25$28.12Jul 25, 25$28.43Jul 29, 25$28.07Jul 31, 25$26.67Aug 4, 25$26.96Aug 6, 25$23.61Aug 11, 25$22.02Aug 13, 25$23.66Aug 15, 25$22.70Aug 19, 25$23.60Aug 21, 25$23.43Aug 25, 25$23.78Aug 27, 25$23.89Aug 29, 25$23.74Sep 3, 25$23.33Sep 5, 25$22.65Sep 9, 25$22.28Sep 11, 25$22.55Sep 16, 25$21.37Sep 18, 25$21.38Sep 22, 25$20.81Sep 24, 25$21.39Sep 26, 25$21.45Sep 30, 25$22.27Oct 2, 25$22.15Oct 6, 25$22.05Oct 8, 25$21.65Oct 10, 25$21.25Oct 14, 25$21.66Oct 16, 25$21.53Oct 21, 25$21.93Oct 23, 25$21.50Oct 27, 25$21.94Oct 29, 25$21.28Oct 31, 25$20.74Nov 4, 25$20.19Nov 6, 25$14.93Nov 10, 25$14.25Nov 12, 25$14.16Nov 14, 25$13.78Nov 18, 25$13.39Nov 20, 25$12.26Nov 25, 25$12.92Nov 28, 25$13.35Dec 2, 25$13.61Dec 4, 25$13.49Dec 8, 25$13.08Dec 10, 25$13.52Dec 12, 25$13.14Dec 16, 25$13.02Dec 18, 25$13.31Dec 22, 25$13.45Dec 24, 25$13.75Dec 29, 25$13.91Jan 2, 26$13.89Jan 6, 26$14.75Jan 8, 26$14.70Jan 12, 26$14.94Jan 14, 26$14.86Jan 16, 26$15.03Jan 21, 26$14.91Jan 23, 26$14.72Jan 27, 26$14.00Jan 29, 26$13.74Feb 2, 26$14.32Feb 4, 26$14.71Feb 9, 26$14.32Feb 11, 26$14.60Feb 13, 26$14.54Feb 18, 26$14.58Feb 20, 26$14.97Feb 24, 26$14.61Feb 26, 26$14.19Mar 2, 26$12.34Mar 4, 26$11.69Mar 6, 26$10.72Mar 10, 26$10.10Mar 12, 26$9.42Mar 17, 26$10.30Mar 19, 26$9.65Mar 23, 26$9.57Mar 25, 26$9.69Mar 27, 26$9.53Mar 31, 26$10.74Apr 2, 26$10.85Apr 7, 26$10.56Apr 9, 26$10.60Apr 13, 26$11.31Apr 15, 26$11.41Apr 17, 26$11.80Apr 22, 26$11.82Apr 24, 26$11.82Apr 28, 26$11.51Apr 30, 26$11.84May 4, 26$11.39May 6, 26$12.26May 8, 26$11.71May 12, 26$11.12May 14, 26$10.84May 18, 26$10.68May 20, 26$11.16May 22, 26$11.22May 28, 26$11.44Jun 1, 26$10.76Jun 3, 26$10.46Jun 5, 26$10.83Jun 9, 26$11.18Jun 11, 26$10.90Jun 15, 26$10.70Jun 17, 26$10.16Jun 22, 26$9.60Jun 24, 26$9.76Jun 26, 26$9.95Jul 2, 26$11.02
$9.2552-week range$28.43
Loading valuation history…

Fundamentals

Key fundamentals

$1.6B

Market cap

-2.8%

Revenue growth (YoY)

35.1%

Gross margin

$145.1M

Free cash flow (USD)

$3.4B

Net debt

0.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$5.3BFY 2017$4.9BFY 2018$4.7BFY 2019$3.9BFY 2020$4.1BFY 2021$4.1BFY 2022$4.5BFY 2023$4.7BFY 2024$4.4BFY 2025$4.3B
$5.3B$4.3B

Free cash flow by year

2016 → 2025

FY 2016$548.7MFY 2017$610.3MFY 2018$490.4MFY 2019$250.1MFY 2020$465.8MFY 2021$4.2MFY 2022$210.9MFY 2023$303.8MFY 2024$244.6MFY 2025$145.1M
$548.7M$145.1M

Gross margin by year

2021 → 2025

FY 202134.2%FY 202232.7%FY 202336.1%FY 202435.3%FY 202535.1%
34.2%35.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDirector AppointmentJun 30, 2026Filing
  • 8-K eventCEO Resignation and AppointmentJun 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventLong-Term Incentive Plan AdoptedMay 5, 2026Filing
  • 8-K eventAcquisition AnnouncedApr 30, 2026Filing
  • 8-K eventSegment Reporting ChangeApr 22, 2026Filing

Questions

Frequently asked questions

What is Perrigo Company plc's market cap?

Perrigo Company plc (PRGO) has a market capitalization of $1.6B.

What is PRGO's P/E ratio?

A meaningful P/E ratio is not available for PRGO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PRGO's price-to-book (P/B) ratio?

PRGO trades at 0.53 times book value per share.

Are insiders buying PRGO stock?

SEC Form 4 filings show no open-market insider buys at Perrigo Company plc in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

ANIP

ANI Pharmaceuticals, Inc.

$1.8B

HROW

Harrow Health, Inc.

$1.3B

PAHC

Phibro Animal Health Corporation

$1.3B

BHC

Bausch Health Companies Inc.

$2B

HCM

HUTCHMED (China) Limited

$2B

EVO

Evotec SE

$1.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.